Núria Eritja
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Endometrial and Cervical Cancer Treatments 11
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Xavier Matías‐GuiuXavier DolcetMarı́a SantacanaAndrée YeramianDavid Llobet‐NavàsMario EncinasSónia GatiusAnabel Sorolla
- Journals
- Cancers (5 papers)American Journal Of Pathology (3 papers)Frontiers in Cell and Developmental Biology (2 papers)European Journal of Cancer (2 papers)The Journal of Pathology (2 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Núria Eritja
40 papers receiving 757 citations
Peers
Comparison fields: 5 of 79
- Obstetrics and Gynecology 148
- Cancer Research 202
- Reproductive Medicine 95
- Oncology 191
- Molecular Biology 449
Countries citing papers authored by Núria Eritja
This map shows the geographic impact of Núria Eritja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria Eritja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria Eritja more than expected).
Fields of papers citing papers by Núria Eritja
This network shows the impact of papers produced by Núria Eritja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria Eritja. The network helps show where Núria Eritja may publish in the future.
Co-authors
The 25 scholars most cited alongside Núria Eritja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 10 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 6 | |
| 6 | 2020 | 17 | |
| 7 | 2019 | 19 | |
| 8 | 2017 | 22 | |
| 9 | 2017 | 23 | |
| 10 | 2016 | 13 | |
| 11 | 2014 | 11 | |
| 12 | 2014 | 9 | |
| 13 | 2014 | 26 | |
| 14 | 2012 | 11 | |
| 15 | 2010 | 39 | |
| 16 | 2010 | 39 | |
| 17 | 2008 | 26 | |
| 18 | 2008 | 18 | |
| 19 | 2008 | 30 | |
| 20 | 2007 | 45 |
About Núria Eritja
Núria Eritja is a scholar working on Obstetrics and Gynecology, Cancer Research, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 40 papers that have together received 768 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (11 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), TGF-β signaling in diseases (6 papers), Cancer Cells and Metastasis (5 papers), Cell death mechanisms and regulation (4 papers), Cancer Mechanisms and Therapy (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Obstetrics and Gynecology (148 citations), Cancer Research (202 citations), Reproductive Medicine (95 citations), Oncology (191 citations) and Molecular Biology (449 citations). Núria Eritja has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Xavier Matías‐Guiu, Xavier Dolcet, Marı́a Santacana, Andrée Yeramian, David Llobet‐Navàs, Mario Encinas, Sónia Gatius, Anabel Sorolla, Judit Pallarés and Ana Velasco. Their work appears in journals such as Cancers, American Journal Of Pathology, Frontiers in Cell and Developmental Biology, European Journal of Cancer and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.